UPLC/MS for the identification of β-blockers
- 24 February 2006
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 40 (3) , 571-580
- https://doi.org/10.1016/j.jpba.2005.11.028
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Increasing throughput and information content for in vitro drug metabolism experiments using ultra‐performance liquid chromatography coupled to a quadrupole time‐of‐flight mass spectrometerRapid Communications in Mass Spectrometry, 2005
- Peak capacity in gradient ultra performance liquid chromatography (UPLC)Journal of Pharmaceutical and Biomedical Analysis, 2005
- HPLC-MS-based methods for the study of metabonomicsJournal of Chromatography B, 2004
- Screening for library-assisted identification and fully validated quantification of 22 beta-blockers in blood plasma by liquid chromatography–mass spectrometry with atmospheric pressure chemical ionizationJournal of Chromatography A, 2004
- Ultra‐performance liquid chromatography coupled to quadrupole‐orthogonal time‐of‐flight mass spectrometryRapid Communications in Mass Spectrometry, 2004
- Prediction of isotope patterns for partially deuterated analytes in HPLC/MSJournal of Pharmaceutical and Biomedical Analysis, 2004
- Use of on‐line hydrogen/deuterium exchange to facilitate metabolite identificationRapid Communications in Mass Spectrometry, 2001
- The Use of Deuterium Oxide as a Mobile Phase for Structural Elucidation by HPLC/UV/ESI/MSAnalytical Chemistry, 2000
- Optimization of mobile phase in the separation of β-blockers by HPLCJournal of Pharmaceutical and Biomedical Analysis, 1998
- Deuterium oxide as a reagent for the modification of mass spectra in electrospray microcolumn liquid chromatography—mass spectrometryJournal of Chromatography A, 1993